Veru (NASDAQ:VERU - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.01, Zacks reports. Veru had a negative net margin of 223.85% and a negative return on equity of 92.88%.
Veru Trading Up 3.0 %
Shares of VERU traded up $0.02 during trading hours on Monday, reaching $0.54. 1,855,548 shares of the company traded hands, compared to its average volume of 6,253,218. The firm has a market cap of $79.24 million, a price-to-earnings ratio of -1.93 and a beta of -0.54. Veru has a 12-month low of $0.40 and a 12-month high of $1.92. The stock's fifty day moving average price is $0.71 and its 200 day moving average price is $0.76.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on VERU. HC Wainwright reiterated a "buy" rating and set a $3.00 price objective on shares of Veru in a research report on Thursday, January 2nd. Oppenheimer reiterated an "outperform" rating and set a $5.00 price objective on shares of Veru in a research report on Tuesday, November 5th.
Read Our Latest Analysis on VERU
About Veru
(
Get Free Report)
Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
See Also
Before you consider Veru, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veru wasn't on the list.
While Veru currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
